PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: marketing

Advantage - GLP-1 - NMSHP - Slides

Maximizing the Role of GLP-1 Agonists in Our Patients with Ty p e 2 D i a b e t e s Curtis L. Triplitt, , CDE Associate Director, Diabetes Research Center, Texas Diabetes Institute Associate Professor, Department of Medicine, Division of Diabetes University of Texas Health Science Center at San Antonio San Antonio, Texas Disclosures Curtis Triplitt, , CDE, declares he has served on speakers bureaus for AstraZeneca and Boehringer Ingelheim. All other faculty and planners report no financial relationships relevant to this activity. Objectives Review the effect of GLP-1 on glucose metabolism. Compare pathophysiologic mechanisms of GLP-1 agonists to other diabetes medications. Discuss the differentiating characteristics of available GLP-1 agonists including long-term safety. Explain the importance of proper injection device technique in the preparation and administration of GLP-1 agonists in the management of type 2 diabetes. Strategize how to overcome barriers in GLP-1 agonist use.

GLP-1 Agonists ! Actions: – Restore glucose-stimulated insulin secretion and first phase insulin – Suppress inappropriate glucagon secretion

Fullscreen Download
Loading..

Tags:

  Slides, Insulin

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Advantage - GLP-1 - NMSHP - Slides

Documents from same domain

Technician's Role in Preventing Adverse Drug Events

nmshp.org

Adverse Drug Events from Specific Medicines Continued: Anticoagulants -Anticoagulants (blood thinners) are important for preventing and treating blood clots, but are associated with an

  Drug, Events, Preventing, Adverse, Adverse drug events, Preventing adverse drug events

Related documents

TEACHING OBJECTIVES: Insulin 1. Demonstrate …

www.ucdenver.edu

80 Chapter 9 – Drawing Up and Giving Insulin The amount of insulin the syringe will hold varies. There are 3/10cc and 1/2cc syringes for people using less than 30 or 50 units of

  Teaching, Objectives, Syringes, Insulin, Demonstrates, Teaching objectives, Insulin 1

Guide for Storage of Insulin - Frio

frio.ir

Storage Conditions for Insulin Cartridges Maximum Storage Conditions for Syringes Predrawn or Vials Premixed* *(post drug manufacturer by pharmacist, patient and/or other health care professional)

  Guide, Storage, Syringes, Insulin, Guide for storage of insulin

Pseudo-DIN List - Canadian Benefit Provider

www.cbproviders.ca

Product Package Size Pseudo-DIN Syringes Con’t UltiCare Insulin Syringe 0.5cc, 30g 100 97799995 UltiCare Insulin Syringe 1.0cc, 29g 100 97799997

  Lists, Syringes, Insulin, Pseudo din list, Pseudo

Guideline for the Administration of Insulin by …

www.nhslanarkshire.org.uk

Page 1 of 5 . Guideline for the Administration of Insulin by Nursing Staff . Aims and objectives

  Administration, Guidelines, Insulin, Guideline for the administration of insulin

Lantus SOLOSTAR - Sanofi

products.sanofi.ca

Page 1 LANTUS ® SOLOSTAR ® Instruction Leaflet . SoloSTAR ® is a prefilled pen for the injection of insulin. Your health professional has decided that SoloSTAR is appropriate for you, based on your ability to handle SoloSTAR.

  Insulin, Lantus, Lantus solostar, Solostar, 174 solostar

Appendix I: Glucose Conversion Between mg/dl …

www.ucdenver.edu

Appendix I: Glucose Conversion Between mg/dl and mmol/L This is the fourth edition of this book to include all blood glucose levels in both mg/dl and

  Between, Appendix, Conversion, Glucose, Appendix i, Glucose conversion between mg dl

Related search queries

TEACHING OBJECTIVES: Insulin 1. Demonstrate, Insulin, Syringes, Guide for Storage of Insulin, Pseudo-DIN List, Guideline for the Administration of Insulin, Lantus SOLOSTAR, LANTUS ® SOLOSTAR, Appendix I: Glucose Conversion Between mg/dl